CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Metallic stents in benign biliary strictures: Three-year follow-up
Authors
A Adam
A Gillams
+19 more
CH Carrasco
Filippo Maria Salvatori
Francesca Maccioni
HG Coons
HP Rousseau
J Lammer
JC Palmaz
JC Palmaz
JD Irving
Mario Bezzi
Michele Rossi
P Rossi
P Rossi
Paolo Ricci
Plinio Rossi
R Albarado
RW Gunther
SJ Citron
W Cwikiel
Publication date
1 January 1992
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Eighteen patients with recurrent benign biliary strictures (BBS) were selected for metallic stents placement because they failed to respond to percutaneous balloon dilatation. None were candidates for surgical corrections. We used "Z" single or double stents in 17 cases and a Wallstent in 1 case. After more than 3 years of follow-up (average period 37 months, range 30-41 months), 10 patients (55.5%) were asymptomatic without signs of bile statis; 5 patients (27.7%) had recurrence of symptoms and were eventually retreated; and 3 patients (16.6%) died, 2 of obstructive jaundice and liver failure and 1 of metastatic gastric cancer. Recurrence was due to stent occlusion by tissue ingrowth in 3 cases, stent migration in 1 case, and an inflammatory lesion of the papilla of Vater in another case, with patency of the metallic stent. The overall patency rate, at 3-year follow-up was 68.7%. In our series, the main factor determining long-term patency of metallic stents has been reactive tissue ingrowth. Nevertheless, long-term results obtained with metallic stents in recurrent benign biliary strictures should be considered satisfactory. In selected patients, metallic stents may represent the only long-term treatment available for maintaining bile flow. © 1992 Springer-Verlag New York Inc
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 11/12/2019
Archivio della ricerca- Università di Roma La Sapienza
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:iris.uniroma1.it:11573/497...
Last time updated on 12/11/2016